European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update

European Urology

Volumn 68, Issue 5, 2015, Pages 868-879

  Rouprêt, Morgan ^a   Babjuk, Marko ^b   Compérat, Eva ^a   Zigeuner, Richard ^c   Sylvester, Richard J ^d   Burger, Maximilian ^e   Cowan, Nigel C ^f   Böhle, Andreas ^g   Van Rhijn, Bas W G ^h   Kaasinen, Eero ⁱ   Palou, Joan ^j   Shariat, Shahrokh F ^k,l,m  

^a INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Italy   (Netherlands)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^g HELIOS AGNES KARLL HOSPITAL   (Germany)

^h ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

ⁱ HYVINKÄÄ HOSPITAL   (Finland)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l WEILL CORNELL MEDICAL COLLEGE   (United States)

^m UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Cytology; Guidelines; Nephroureterectomy; Renal pelvis; Risk factors; Survival; Ureter; Ureteroscopy; Urinary tract cancer; Urothelial carcinoma

Indexed keywords

MITOMYCIN; MOLECULAR MARKER; TOPICAL AGENT; ANTINEOPLASTIC ANTIBIOTIC;

BLADDER CANCER; BLADDER IRRIGATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CYSTOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; ENVIRONMENTAL FACTOR; ETHNICITY; FOLLOW UP; HUMAN; KIDNEY PELVIS CANCER; KIDNEY SPARING SURGERY; KIDNEY SURGERY; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; NEPHROURETERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOBACCO CONSUMPTION; TRANSITIONAL CELL CARCINOMA; UPPER URINARY TRACT UROTHELIAL CELL CARCINOMA; URETER CANCER; URETEROSCOPY; URETEROURETEROSTOMY; URINARY TRACT CARCINOMA; URINE CYTOLOGY; UROGRAPHY; ADJUVANT CHEMOTHERAPY; CARCINOMA, TRANSITIONAL CELL; INTRAVESICAL DRUG ADMINISTRATION; KIDNEY NEOPLASMS; KIDNEY PELVIS; MEDICAL SOCIETY; NEPHRECTOMY; PATHOLOGY; PREVENTION AND CONTROL; SURGERY; TUMOR RECURRENCE; URETER; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROLOGY;

ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; SOCIETIES, MEDICAL; URETER; URETERAL NEOPLASMS; URETEROSCOPY; URINARY BLADDER NEOPLASMS; UROLOGY;

EID: 84942985971     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.06.044     Document Type: Article

References (80)

1. M. Rouprêt, M. Babjuk, E. Compérat, and et al. European guidelines on upper tract urothelial carcinomas: 2013 update Eur Urol 63 2013 1059 1071
2. Oxford Centre for Evidence-based Medicine - levels of evidence (March 2009). Center for Evidence-based Medicine Web site. http://www.cebm.net/index.aspx?o=1025. Updated January 29, 2013.
3. M. Babjuk, M. Burger, R. Zigeuner, and et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013 Eur Urol 64 2013 639 653
4. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
5. M. Cosentino, J. Palou, J.M. Gaya, A. Breda, O. Rodriguez-Faba, and H. Villavicencio-Mavrich Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma World J Urol 31 2013 141 145
6. E. Xylinas, M. Rink, V. Margulis, P. Karakiewicz, G. Novara, and S.F. Shariat Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence Eur Urol 61 2012 1069 1070
7. W.M. Li, J.T. Shen, C.C. Li, and et al. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma Eur Urol 57 2010 963 969
8. V. Margulis, S.F. Shariat, S.F. Matin, and et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224 1233
9. S.F. Shariat, R.L. Favaretto, A. Gupta, and et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma World J Urol 29 2011 481 486
10. M. Rouprêt, D.R. Yates, E. Compérat, and O. Cussenot Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum Eur Urol 54 2008 1226 1236
11. F. Audenet, P. Colin, D.R. Yates, and et al. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool BJU Int 110 2012 E583 E589
12. P. Acher, G. Kiela, K. Thomas, and T. O'Brien Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma BJU Int 106 2010 300 302
13. P. Colin, P. Koenig, A. Ouzzane, and et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract BJU Int 104 2009 1436 1440
14. A.P. Grollman, S. Shibutani, M. Moriya, and et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy Proc Natl Acad Sci U S A 104 2007 12129 12134
15. M. Rouprêt, S.J. Drouin, G. Cancel-Tassin, E. Compérat, S. Larre, and O. Cussenot Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis J Urol 187 2012 424 428
16. M. Rink, B.D. Robinson, D.A. Green, and et al. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma J Urol 188 2012 398 404
17. A. Masson-Lecomte, P. Colin, G. Bozzini, and et al. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma World J Urol 32 2014 531 537
18. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors ed. 7. 2009 Wiley-Blackwell Hoboken, NJ
19. M. Roscigno, E.K. Cha, M. Rink, and et al. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis BJU Int 110 2012 674 681
20. J. Park, T. Habuchi, Y. Arai, and et al. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems J Urol 192 2014 1064 1071
21. A. Lopez-Beltran, T. Gasser, A. Hartmann, and et al. Tumours of the urinary system. In: World Health Organisation classification of tumors: pathology and genetics of tumours of the urinary system and male genital organs 2004 IARC Press Lyon, France 86 157
22. J.D. Raman, S.F. Shariat, P.I. Karakiewicz, and et al. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29 2011 716 723
23. Y. Ito, E. Kikuchi, N. Tanaka, and et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma J Urol 185 2011 1621 1626
24. N.C. Cowan, B.W. Turney, N.J. Taylor, C.L. McCarthy, and J.P. Crew Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour BJU Int 99 2007 1363 1370
25. J.C. Messer, J.D. Terrell, M.P. Herman, and et al. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma Urol Oncol 31 2013 904 908
26. S. Hurel, M. Rouprêt, T. Seisen, and et al. Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy World J Urol 33 2015 335 341
27. J. Messer, S.F. Shariat, J.C. Brien, and et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma BJU Int 108 2011 701 705
28. C.P. Rojas, S.M. Castle, C.A. Llanos, and et al. Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma Urol Oncol 31 2013 1696 1700
29. T. Clements, J.C. Messer, J.D. Terrell, and et al. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection J Endourol 26 2012 398 402
30. G. Lughezzani, M. Burger, V. Margulis, and et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature Eur Urol 62 2012 100 114
31. T.F. Chromecki, B. Ehdaie, G. Novara, and et al. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy World J Urol 29 2011 473 480
32. K. Matsumoto, G. Novara, A. Gupta, and et al. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study BJU Int 108 2011 E304 E309
33. M. Rink, E. Xylinas, V. Margulis, and et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy Eur Urol 63 2013 1082 1090
34. E. Xylinas, L.A. Kluth, M. Rieken, and et al. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy BJU Int 114 2014 56 61
35. F.A. Yafi, G. Novara, S.F. Shariat, and et al. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy BJU Int 110 2012 E7 E13
36. A. Ouzzane, P. Colin, E. Xylinas, and et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy Eur Urol 60 2011 1258 1265
37. T.F. Chromecki, E.K. Cha, H. Fajkovic, and et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy Eur Urol 61 2012 245 253
38. A.K. Williams, W. Kassouf, J. Chin, and et al. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma Urol Oncol 31 2013 1161 1165
39. D. Sundi, R.S. Svatek, V. Margulis, and et al. Upper tract urothelial carcinoma: impact of time to surgery Urol Oncol 30 2012 266 272
40. A.J. Gadzinski, W.W. Roberts, G.J. Faerber, and J.S. Wolf Jr. Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma J Endourol 26 2012 566 573
41. J.N. Lee, S.Y. Kwon, G.S. Choi, and et al. Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma J Surg Oncol 110 2014 468 475
42. A.A. Berod, P. Colin, D.R. Yates, and et al. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study BJU Int 110 2012 E1035 E1040
43. J.I. Martinez-Salamanca, S.F. Shariat, J.C. Rodriguez, and et al. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study BJU Int 109 2012 1155 1161
44. B. Ehdaie, T.F. Chromecki, R.K. Lee, and et al. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma J Urol 186 2011 66 72
45. M. Roscigno, M. Brausi, A. Heidenreich, and et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer Eur Urol 60 2011 776 783
46. M.S. Godfrey, G.M. Badalato, G.W. Hruby, M. Razmjoo, and J.M. McKiernan Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion BJU Int 110 2012 798 803
47. P. Colin, A. Ouzzane, D.R. Yates, and et al. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival Ann Surg Oncol 19 2012 3613 3620
48. R. Zigeuner, S.F. Shariat, V. Margulis, and et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract Eur Urol 57 2010 575 581
49. M. Remzi, A. Haitel, V. Margulis, and et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients BJU Int 103 2009 307 311
50. H.M. Fritsche, G. Novara, M. Burger, and et al. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma Urol Oncol 30 2012 666 672
51. W. Otto, S.F. Shariat, H.M. Fritsche, and et al. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients World J Urol 29 2011 487 494
52. J.C. Wheat, A.Z. Weizer, J.S. Wolf Jr., and et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy Urol Oncol 30 2012 252 258
53. S. Scarpini, M. Rouprêt, R. Renard-Penna, P. Camparo, O. Cussenot, and E. Compérat Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract Urol Oncol 30 2012 182 187
54. C. Feng, L. Wang, G. Ding, and et al. Predictive value of clinicopathological markers for the metachronous bladder cancer and prognosis of upper tract urothelial carcinoma Sci Rep 4 2014 4015
55. M. Rouprêt, G. Fromont, A.R. Azzouzi, and et al. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma Urology 65 2005 1233 1237
56. R.L. Favaretto, S.F. Shariat, C. Savage, and et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma BJU Int 109 2012 77 82
57. T. Seisen, P. Colin, V. Hupertan, and et al. Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis BJU Int 114 2014 733 740
58. M. Rouprêt, V. Hupertan, T. Seisen, and et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis J Urol 189 2013 1662 1669
59. R. Yakoubi, P. Colin, T. Seisen, and et al. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies Eur J Surg Oncol 40 2014 1629 1634
60. M.L. Cutress, G.D. Stewart, P. Zakikhani, S. Phipps, B.G. Thomas, and D.A. Tolley Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review BJU Int 110 2012 614 628
61. M. Rouprêt, O. Traxer, M. Tligui, and et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection Eur Urol 51 2007 709 714 discussion 714
62. C. Jeldres, G. Lughezzani, M. Sun, and et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter J Urol 183 2010 1324 1329
63. G. Lughezzani, C. Jeldres, H. Isbarn, and et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients Eur J Cancer 45 2009 3291 3297
64. P. Colin, A. Ouzzane, G. Pignot, and et al. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study BJU Int 110 2012 1134 1141
65. G. Giannarini, T.M. Kessler, F.D. Birkhauser, G.N. Thalmann, and U.E. Studer Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol 60 2011 955 960
66. G. Lughezzani, M. Sun, P. Perrotte, and et al. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study Eur Urol 57 2010 956 962
67. E. Xylinas, M. Rink, E.K. Cha, and et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma Eur Urol 65 2014 210 217
68. E. Xylinas, L. Kluth, N. Passoni, and et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool Eur Urol 65 2014 650 658
69. R.L. Favaretto, S.F. Shariat, D.C. Chade, and et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58 2010 645 651
70. S. Ni, W. Tao, Q. Chen, and et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies Eur Urol 61 2012 1142 1153
71. M.M. Ariane, P. Colin, A. Ouzzane, and et al. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study Ann Surg Oncol 19 2012 301 308
72. M. Adibi, R. Youssef, S.F. Shariat, and et al. Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades Int J Urol 19 2012 1060 1066
73. T. O'Brien, E. Ray, R. Singh, B. Coker, and R. Beard Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial) Eur Urol 60 2011 703 710
74. A. Ito, I. Shintaku, M. Satoh, and et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial J Clin Oncol 31 2013 1422 1427
75. D. Fang, X.S. Li, G.Y. Xiong, L. Yao, Z.S. He, and L.Q. Zhou Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis Urol Int 91 2013 291 296
76. M.G. Kaag, R.L. O'Malley, P. O'Malley, and et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy Eur Urol 58 2010 581 587
77. S.F. Matin, V. Margulis, A. Kamat, and et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma Cancer 116 2010 3127 3134
78. M. Vassilakopoulou, T. de la Motte Rouge, P. Colin, and et al. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study Cancer 117 2011 5500 5508
79. J.J. Leow, W. Martin-Doyle, A.P. Fay, T.K. Choueiri, S.L. Chang, and J. Bellmunt A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma Eur Urol 66 2014 529 541
80. G. Ploussard, E. Xylinas, Y. Lotan, and et al. Conditional survival after radical nephroureterectomy for upper tract carcinoma Eur Urol 67 2015 803 812